This page was translated automatically from Turkish. Read the original
Bu sayfa, 26. Dünya Psikiyatri Kongresi'nde sunulan çalışmanın yapay zekâ desteğiyle hazırlanmış Türkçe özetidir. Çalışmanın sahibi sunan yazarlardır; atıf için orijinal kaynağa başvurun.
EV1105
Antipsychotic-associated metabolic syndrome in schizophrenia: a bibliometric analysis of global research (2000–2026)
FROM ANTIPSYCHOTIC EFFICACY TO METABOLIC SAFETY: A BIBLIOMETRIC ANALYSIS OF SCHIZOPHRENIA RESEARCH (2000–2026)
Sunan: Hevidar Akbulut
Ülke: Turkey
The focus of schizophrenia research shifted from antipsychotic efficacy to long-term metabolic safety between 2000 and 2026.
The study aims to map the development and prominent themes of research on metabolic complications associated with long-term antipsychotic treatment in schizophrenia. English-language articles and reviews published between 2000 and 2026 were retrieved from the Web of Science Core Collection and PubMed; the WoS dataset (n = 7,247) was analyzed using Bibliometrix/Biblioshiny and VOSviewer to examine publication trends, citation patterns, collaboration networks, intellectual and conceptual structure, and thematic evolution. Across the 7,247 publications, the findings showed a marked increase in research output from 2000 to 2026. The most prolific journal was Schizophrenia Research, with 387 documents, followed by Journal of Clinical Psychiatry (275), Journal of Clinical Psychopharmacology (190), Frontiers in Psychiatry (142), BMC Psychiatry (132), and Psychiatry Research (129). Thematic analysis identified a clear shift from antipsychotic efficacy to metabolic safety, with metabolic syndrome, diabetes, obesity, and cardiometabolic health emerging as major research themes. Overall, the field has become increasingly interdisciplinary and collaborative. The authors note that this trend reflects the integration of psychiatry, metabolic medicine, and personalized treatment approaches. Clinically, the findings indicate that metabolic safety in antipsychotic selection and monitoring has become one of the field’s primary priorities.
Orijinal postere gitBu çalışmaya nasıl atıf yapılır?
APA 7: Akbulut, H., et al. (2026, September 23-26). From antipsychotic efficacy to metabolic safety: a bibliometric analysis of schizophrenia research (2000–2026) [E-poster]. 26th WPA World Congress of Psychiatry (WCP 2026), Stockholm, Sweden. https://cslide.ctimeetingtech.com/wcp26/attendee/eposter/file/1929
Vancouver: Akbulut H, et al. From antipsychotic efficacy to metabolic safety: a bibliometric analysis of schizophrenia research (2000–2026) [e-poster]. 26th WPA World Congress of Psychiatry (WCP 2026); 2026 Sep 23-26; Stockholm, Sweden. Available from: https://cslide.ctimeetingtech.com/wcp26/attendee/eposter/file/1929
Yazar adları ve başlık biçimi kongre sisteminden otomatik oluşturulmuştur; kullanmadan önce orijinal posterle karşılaştırın.
Aynı konudan
- Açığı kapatmak: erişkin DEHB ilacı başlanmadan önce EKG sevk uyumunun iyileştirilmesi, kapalı döngü klinik denetim
- Anksiyete bozukluğu olan hastalarda psikobiyotik müdahalesi: ısıl işlem görmüş Lactobacillus paracasei PS23'ün etkilerini inceleyen çift kör randomize kontrollü çalışma
- Otizm spektrum bozukluğunda bumetanidin tedavi edici potansiyeli: güncel kanıtlar ve gelecek yönelimleri
- Verbaskozid ile otizm spektrum bozukluğu tedavisinin mekanizmaları: ağ farmakolojisi, moleküler yerleştirme ve moleküler dinamik temelli inceleme
- Otizm spektrum bozukluğunun çekirdek belirtilerinin tedavisinde kannabidiol: sistematik derleme